We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Parkinson's Disease Registry of the Muhammad Ali Parkinson Center

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by Muhammad Ali Parkinson Research Center.
Recruitment status was:  Active, not recruiting
ClinicalTrials.gov Identifier:
First Posted: September 22, 2005
Last Update Posted: July 21, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Barrow Neurological Foundation
Information provided by:
Muhammad Ali Parkinson Research Center

The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. It will also be a means for investigators in the field of PD to quickly identify and notify subjects about other research studies for which they are eligible.

Objectives include:

  • Assess current treatment approaches and develop best-practice guidelines
  • Track the functional abilities, access to healthcare and cost of illness of people with PD over time
  • Drive the development of innovative research projects
  • Accelerate the process of informing patients of research projects for which they may be eligible

Parkinson's Disease

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Parkinson's Disease Registry

Resource links provided by NLM:

Further study details as provided by Muhammad Ali Parkinson Research Center:

Estimated Enrollment: 20000
Study Start Date: November 2003
Estimated Study Completion Date: December 2015
Detailed Description:

What do you need to know?

  • Any individual diagnosed with PD is eligible to enroll.
  • Participation in the registry is voluntary, confidential and free of charge.
  • Eligible participants will be notified about opportunities to participate in clinical trials, though they are under no obligation to enter.
  • Participants will need to complete an updated questionnaire every six months.
  • Participants may also be asked to complete additional surveys for PD research projects.
  • Any data provided will be used in scientific publications in summary form only.
  • Participant names will not be released to anyone outside the Parkinson's disease Registry management team without written authorization, nor will names be sold for advertising or fund-raising purposes.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants must be over 18 years old, have idiopathic Parkinson's disease diagnosed by a physician.

Inclusion Criteria:

  • Clinical diagnosis of Parkinson's disease

Exclusion Criteria:

  • No clinical diagnosis of Parkinson's disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00217321

United States, Arizona
Muhammad Ali Parkinson Research Center
Phoenix, Arizona, United States, 85013
Sponsors and Collaborators
Muhammad Ali Parkinson Research Center
Barrow Neurological Foundation
Principal Investigator: Abraham Lieberman, MD MAPC
  More Information

Responsible Party: Patty Hatton, CTRS/Coordinator, Barrow Neurological Institute
ClinicalTrials.gov Identifier: NCT00217321     History of Changes
Other Study ID Numbers: 03BN117
First Submitted: September 15, 2005
First Posted: September 22, 2005
Last Update Posted: July 21, 2010
Last Verified: September 2006

Keywords provided by Muhammad Ali Parkinson Research Center:
Parkinson's disease
Parkinson disease
quality of life

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases